Wendy Guy

Insider Reports History

Reporting-owner location: Vero Beach, FL
Latest reporting-owner signature: /s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Wendy Guy

Form 4 holding Chief Administrative Officer

Processa Pharmaceuticals, Inc.

Security class: Restricted Stock Units
Shares / value: 11,669
Estimated value: $42,603
Report date: 26 Jul 2026
Price: $1.71
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Administrative Officer

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 14,394
Estimated value: $36,272
Report date: 26 Jul 2026
Price: $2.52
Ownership: Direct

Form 4 holding Chief Administrative Officer

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 333
Estimated value: $839
Report date: 26 Jul 2026
Price: $2.52
Ownership: By CorLyst, LLC

Form 4 holding Chief Administrative Officer

Processa Pharmaceuticals, Inc.

Security class: Stock Options (Right to Buy)
Shares / value: 6,000
Estimated value
Report date: 26 Jul 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Wendy Guy

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 26 Jul 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Jul 2026, 20:22
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 30 Jun 2026
Transactions: 1
Transaction value: +$4,701
Accepted by SEC: 01 Jul 2026, 16:20
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 15 Jun 2026
Transactions: 1
Transaction value: +$4,702
Accepted by SEC: 16 Jun 2026, 16:20
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 29 May 2026
Transactions: 1
Transaction value: +$4,701
Accepted by SEC: 01 Jun 2026, 16:55
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 15 May 2026
Transactions: 1
Transaction value: +$4,702
Accepted by SEC: 19 May 2026, 17:37
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 30 Apr 2026
Transactions: 1
Transaction value: +$4,702
Accepted by SEC: 01 May 2026, 16:35
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 15 Apr 2026
Transactions: 1
Transaction value: +$4,702
Accepted by SEC: 17 Apr 2026, 16:51
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 31 Mar 2026
Transactions: 1
Transaction value: +$4,700
Accepted by SEC: 01 Apr 2026, 17:09
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Jan 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Feb 2026, 17:05
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Oct 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 Oct 2025, 16:33
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 28 Jul 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Jul 2025, 16:36
Role: Chief Administrative Officer
Next action: Open filing details

4/A PCSA

Processa Pharmaceuticals, Inc.

Report period: 24 Jul 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 Sep 2025, 16:27
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Apr 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Apr 2025, 17:20
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 05 Apr 2024
Transactions: 8
Transaction value: -$1,403
Accepted by SEC: 02 Aug 2024, 17:12
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Jan 2024
Transactions: 3
Transaction value: -$1,027
Accepted by SEC: 12 Apr 2024, 16:50
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 12 Oct 2023
Transactions: 1
Transaction value: +$5,022
Accepted by SEC: 12 Oct 2023, 18:07
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 31 Dec 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 04 Jan 2023, 16:47
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 30 Sep 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Oct 2022, 16:57
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 05 Aug 2022
Transactions: 2
Transaction value: -$5,649
Accepted by SEC: 09 Aug 2022, 16:23
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 30 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jul 2022, 17:42
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Apr 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Apr 2022, 17:49
Role: Chief Administrative Officer
Next action: Open filing details

4/A PCSA

Processa Pharmaceuticals, Inc.

Report period: 31 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2022, 16:25
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 01 Nov 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Apr 2022, 17:53
Role: Chief Administrative Officer
Next action: Open filing details

4/A PCSA

Processa Pharmaceuticals, Inc.

Report period: 30 Sep 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2022, 15:00
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 05 Aug 2021
Transactions: 2
Transaction value: -$13,975
Accepted by SEC: 09 Aug 2021, 16:42
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 08 Jul 2021
Transactions: 3
Transaction value: $0
Accepted by SEC: 09 Jul 2021, 16:34
Role: Chief Administrative Officer
Next action: Open filing details

4 PCSA

Processa Pharmaceuticals, Inc.

Report period: 08 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Jun 2021, 17:14
Role: Chief Administrative Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .